Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to reality. On December 22, the U.S. Food and Drug Administration (FDA) approved ...

By Danny Barrett, Jr. University of Mississippi Medical Center JACKSON – Drugs initially approved for diabetes are now an ...

Working with a doctor or nutritionist, older adults can develop a plan for weight management that addresses their individual needs. Weight management can be a complex process for people ages 65 years ...

They’re not directly talking about weight loss as such, but “metabolic support” or “weight management”. Rather than promising overnight results, they claim to work with your body — supporting blood ...

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...

Weight management becomes more complex as people age due to health considerations, mobility challenges, and nutritional factors. Understanding the role of diet and exercise in weight management can ...

After months of rigorous testing and analysis throughout 2025-2026, we are excited to present the most comprehensive review ...

The Food and Drug Administration (FDA) has approved Wegovy ® (semaglutide) tablets, the first oral glucagon-like peptide-1 (GLP-1) receptor agonist for the treatment of obesity.

The FDA has approved Novo Nordisk’s Wegovy pill to reduce excess body weight, support weight management, and maintain weight ...

Weight changes can occur across stages of life due to factors such as hormonal shifts, lifestyle changes, and metabolic variations. Recognizing these connections can aid in developing personalized ...